De Novo Peptide Design with C3a Receptor Agonist and Antagonist Activities: Theoretical Predictions and Experimental Validation()

Targeting the complement component 3a receptor (C3aR) with selective agonists or antagonists is believed to be a viable therapeutic option for several diseases such as stroke, heart attack, reper-fusion injuries, and rheumatoid arthritis. We designed a number of agonists, partial agonists, and antag...

Celý popis

Uloženo v:
Podrobná bibliografie
Hlavní autoři: Bellows-Peterson, Meghan L., Fung, Ho Ki, Floudas, Christodoulos A., Kieslich, Chris A., Zhang, Li, Morikis, Dimitrios, Wareham, Kathryn J., Monk, Peter N., Hawksworth, Owen A., Woodruff, Trent
Médium: Artigo
Jazyk:Inglês
Vydáno: 2012
Témata:
Article
On-line přístup:https://ncbi.nlm.nih.gov/pmc/articles/PMC3349770/
https://ncbi.nlm.nih.gov/pubmed/22500977
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1021/jm201609k
Tagy: Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!

Podobné jednotky